Emergency Department Visits Due to Dyspnea: Association with Inhalation Therapy in COPD and Cases with Adverse Drug Reactions
Open Access
- 10 August 2022
- journal article
- research article
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. 17, 1827-1834
Abstract
Purpose: Dyspnea is a leading symptom of COPD that causes presentations in emergency departments or negatively impacts on them. Guideline-based inhalation therapies are intended to reduce dyspnea in COPD patients. This study analyzed how common guideline recommended inhalation therapy regimens are occurring in clinical practice among COPD patients presenting to emergency departments due to adverse drug reactions in polytherapy using data of the German ADRED database.Patients and Methods: In total, 269 COPD cases were identified. In a further analysis, all cases were analyzed for documented GOLD stage and guideline-recommended inhalation therapy for COPD. Dyspnea and other symptoms identified during ED presentation were analyzed and compared between patients who did and did not receive the guideline's recommended inhalation therapy.Results: In this observation, 41% (n = 46) of all 112 cases with a documented COPD and GOLD stage received an underdosed therapy according to current guidelines. Dyspnea was the most common identified symptom (32%, n = 36) in this cohort and occurred more often in patients who received an underdosage of inhalation therapy (p < 0.01).Conclusion: Patients with COPD presenting to ED with ADRs show a high rate of non-guideline-recommended inhalation therapy and present more often with dyspnea compared to those COPD patients who received an adequate dosing of inhalation therapy.Keywords
This publication has 26 references indexed in Scilit:
- Factores asociados a la hospitalización por exacerbación de la enfermedad pulmonar obstructiva crónicaArchivos de Bronconeumología, 2012
- Factors Associated With Hospital Admission for Exacerbation of Chronic Obstructive Pulmonary DiseaseArchivos de Bronconeumología, 2012
- Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agentsRespiratory Research, 2010
- Susceptibility to Exacerbation in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2010
- Diagnosis and Management of Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care ClinicCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2009
- Adherence to inhaled therapy, mortality and hospital admission in COPDThorax, 2009
- Risk Indexes for Exacerbations and Hospitalizations Due to COPDChest, 2007
- Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study.Thorax, 1995
- The medical dictionary for drug regulatory affairs (MEDDRA) projectPharmacoepidemiology and Drug Safety, 1994
- Dose response relation to oral theophylline in severe chronic obstructive airways disease.BMJ, 1988